Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation


Taxane-induced neuropathy is a frequent complication, in particular in women with breast cancer. The incidence can be variable and ranges from 11 to 87%, depending on the taxane used and identified risk factors, such as cumulative dose, additional neurotoxic chemotherapy agents and previous nerve fragility. However, little is known about long-term outcome… (More)
DOI: 10.1007/s00415-012-6442-5

3 Figures and Tables


  • Presentations referencing similar topics